Role of Perturbated Hemostasis in MASLD and Its Correlation with Adipokines

Salvatore Pezzino,Tonia Luca,Mariacarla Castorina,Stefano Puleo,Saverio Latteri,Sergio Castorina

DOI: https://doi.org/10.3390/life14010093

2024-01-08

Life

Abstract:The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) continues to rise, making it one of the most prevalent chronic liver disorders. MASLD encompasses a range of liver pathologies, from simple steatosis to metabolic dysfunction-associated steatohepatitis (MASH) with inflammation, hepatocyte damage, and fibrosis. Interestingly, the liver exhibits close intercommunication with fatty tissue. In fact, adipose tissue could contribute to the etiology and advancement of MASLD, acting as an endocrine organ that releases several hormones and cytokines, with the adipokines assuming a pivotal role. The levels of adipokines in the blood are altered in people with MASLD, and recent research has shed light on the crucial role played by adipokines in regulating energy expenditure, inflammation, and fibrosis in MASLD. However, MASLD disease is a multifaceted condition that affects various aspects of health beyond liver function, including its impact on hemostasis. The alterations in coagulation mechanisms and endothelial and platelet functions may play a role in the increased vulnerability and severity of MASLD. Therefore, more attention is being given to imbalanced adipokines as causative agents in causing disturbances in hemostasis in MASLD. Metabolic inflammation and hepatic injury are fundamental components of MASLD, and the interrelation between these biological components and the hemostasis pathway is delineated by reciprocal influences, as well as the induction of alterations. Adipokines have the potential to serve as the shared elements within this complex interrelationship. The objective of this review is to thoroughly examine the existing scientific knowledge on the impairment of hemostasis in MASLD and its connection with adipokines, with the aim of enhancing our comprehension of the disease.

biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of coagulation disorders in metabolic - dysfunction - associated steatohepatitis (MASLD) and its correlation with adipokines. Specifically, the paper aims to comprehensively review the existing scientific literature to understand the mechanisms of coagulation disorders in MASLD and clarify the role of adipokines in this process, thereby deepening the understanding of the pathophysiology of MASLD.

### Research background and problem statement

1. **Prevalence trends and complexity of MASLD**:
- MASLD is a common chronic liver disease, and its incidence is continuously rising globally.
- MASLD includes multiple pathological states from simple steatosis to metabolic - dysfunction - associated steatohepatitis (MASH), accompanied by inflammation, hepatocyte injury and fibrosis.

2. **Interaction between adipose tissue and the liver**:
- Adipose tissue not only affects liver metabolism by releasing free fatty acids, but also acts as an endocrine organ to release multiple hormones and cytokines, especially adipokines, which play a key role in regulating energy expenditure, inflammation and fibrosis.
- In MASLD patients, the levels of adipokines in the blood are altered, indicating that adipokines may play an important role in disease progression.

3. **Impact of coagulation disorders**:
- Changes in the coagulation mechanism, fibrinolysis process, and endothelial and platelet functions may increase the susceptibility and disease severity of MASLD patients.
- The liver plays an important role in maintaining the coagulation balance, so its dysfunction may lead to a decrease in the synthesis of coagulation factors, which in turn may cause coagulation abnormalities.

4. **Relationship between adipokines and coagulation function**:
- Studies have shown that unbalanced adipokines may be an important factor leading to coagulation disorders in MASLD patients.
- For example, the level of adipokines such as leptin is positively correlated with the severity of MASLD/MASH, and is accompanied by an increase in platelet activation and aggregation, which may promote arterial thrombosis.

### Main objectives of the paper

- **In - depth study of the mechanisms of coagulation disorders in MASLD**: By reviewing the existing literature, the specific manifestations and potential mechanisms of coagulation disorders in MASLD patients are explored in detail.
- **Reveal the role of adipokines in coagulation disorders**: Analyze how adipokines affect the coagulation mechanism, especially their specific roles in regulating inflammation, platelet function and endothelial function.
- **Provide new treatment ideas**: Through in - depth understanding of the above mechanisms, new perspectives and potential targets for the diagnosis and treatment of MASLD are provided.

In summary, this paper aims to reveal the complex relationship between coagulation disorders and adipokines in MASLD through a systematic review of existing scientific evidence, thereby providing theoretical support for future research and clinical practice.